Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 2697K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Weis, S. Articles by Cheresh, D. Search for Related Content PubMed PubMed Citation Articles by Weis, S. Articles by Cheresh, D. Related Collections Related Article Social Bookmarking                            What's this?

Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis

Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037

Correspondence to David Cheresh: cheresh{at}scripps.edu

Abstract

VEGF is unique among angiogenic growth factors because it disrupts endothelial barrier function. Therefore, we considered whether this property of VEGF might contribute to tumor cell extravasation and metastasis. To test this, mice lacking the Src family kinases Src or Yes, which maintain endothelial barrier function in the presence of VEGF, were injected intravenously with VEGF-expressing tumor cells. We found a dramatic reduction in tumor cell extravasation in lungs or livers of mice lacking Src or Yes. At the molecular level, VEGF compromises the endothelial barrier by disrupting a VE-cadherin–ß-catenin complex in lung endothelium from wild-type, but not Yes-deficient, mice. Disrupting the endothelial barrier directly with anti–VE-cadherin both amplifies metastasis in normal mice and overcomes the genetic resistance in Yes-deficient mice. Pharmacological blockade of VEGF, VEGFR-2, or Src stabilizes endothelial barrier function and suppresses tumor cell extravasation in vivo. Therefore, disrupting Src signaling preserves host endothelial barrier function providing a novel host-targeted approach to control metastatic disease.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Monaghan-Benson, E., Burridge, K. (2009). The Regulation of Vascular Endothelial Growth Factor-induced Microvascular Permeability Requires Rac and Reactive Oxygen Species. J. Biol. Chem. 284: 25602-25611 [Abstract] [Full Text]  
• Xiong, Y., Huo, Y., Chen, C., Zeng, H., Lu, X., Wei, C., Ruan, C., Zhang, X., Hu, Z., Shibuya, M., Luo, J. (2009). Vascular Endothelial Growth Factor (VEGF) Receptor-2 Tyrosine 1175 Signaling Controls VEGF-induced von Willebrand Factor Release from Endothelial Cells via Phospholipase C-{gamma}1- and Protein Kinase A-dependent Pathways. J. Biol. Chem. 284: 23217-23224 [Abstract] [Full Text]  
• Basappa, , Murugan, S., Sugahara, K. N, Lee, C. M., ten Dam, G. B, van Kuppevelt, T. H, Miyasaka, M., Yamada, S., Sugahara, K. (2009). Involvement of chondroitin sulfate E in the liver tumor focal formation of murine osteosarcoma cells. Glycobiology 19: 735-742 [Abstract] [Full Text]  
• Pan, S., World, C. J., Kovacs, C. J., Berk, B. C. (2009). Glucose 6-Phosphate Dehydrogenase Is Regulated Through c-Src-Mediated Tyrosine Phosphorylation in Endothelial Cells. Arterioscler. Thromb. Vasc. Bio. 29: 895-901 [Abstract] [Full Text]  
• Gavard, J., Hou, X., Qu, Y., Masedunskas, A., Martin, D., Weigert, R., Li, X., Gutkind, J. S. (2009). A Role for a CXCR2/Phosphatidylinositol 3-Kinase {gamma} Signaling Axis in Acute and Chronic Vascular Permeability. Mol. Cell. Biol. 29: 2469-2480 [Abstract] [Full Text]  
• Bezuhly, M., Cullen, R., Esmon, C. T., Morris, S. F., West, K. A., Johnston, B., Liwski, R. S. (2009). Role of activated protein C and its receptor in inhibition of tumor metastasis. Blood 113: 3371-3374 [Abstract] [Full Text]  
• Zhu, W., Ou, Y., Li, Y., Xiao, R., Shu, M., Zhou, Y., Xie, J., He, S., Qiu, P., Yan, G. (2009). A Small-Molecule Triptolide Suppresses Angiogenesis and Invasion of Human Anaplastic Thyroid Carcinoma Cells via Down-Regulation of the Nuclear Factor-{kappa}B Pathway. Mol. Pharmacol. 75: 812-819 [Abstract] [Full Text]  
• Funa, N. S., Kriz, V., Zang, G., Calounova, G., Akerblom, B., Mares, J., Larsson, E., Sun, Y., Betsholtz, C., Welsh, M. (2009). Dysfunctional Microvasculature as a Consequence of Shb Gene Inactivation Causes Impaired Tumor Growth. Cancer Res. 69: 2141-2148 [Abstract] [Full Text]  
• Nottebaum, A. F., Cagna, G., Winderlich, M., Gamp, A. C., Linnepe, R., Polaschegg, C., Filippova, K., Lyck, R., Engelhardt, B., Kamenyeva, O., Bixel, M. G., Butz, S., Vestweber, D. (2008). VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. JEM 205: 2929-2945 [Abstract] [Full Text]  
• Granger, A., Abdullah, I., Huebner, F., Stout, A., Wang, T., Huebner, T., Epstein, J. A., Gruber, P. J. (2008). Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J. 22: 3549-3560 [Abstract] [Full Text]  
• Qu, Z., Van Ginkel, S., Roy, A. M., Westbrook, L., Nasrin, M., Maxuitenko, Y., Frost, A. R., Carey, D., Wang, W., Li, R., Grizzle, W. E., Thottassery, J. V., Kern, F. G. (2008). Vascular Endothelial Growth Factor Reduces Tamoxifen Efficacy and Promotes Metastatic Colonization and Desmoplasia in Breast Tumors. Cancer Res. 68: 6232-6240 [Abstract] [Full Text]  
• Ramchandran, R., Mehta, D., Vogel, S. M., Mirza, M. K., Kouklis, P., Malik, A. B. (2008). Critical role of Cdc42 in mediating endothelial barrier protection in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L363-L369 [Abstract] [Full Text]  
• Serban, D., Leng, J., Cheresh, D. (2008). H-Ras Regulates Angiogenesis and Vascular Permeability by Activation of Distinct Downstream Effectors. Circ. Res. 102: 1350-1358 [Abstract] [Full Text]  
• Singleton, P. A., Garcia, J. G.N., Moss, J. (2008). Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis. Molecular Cancer Therapeutics 7: 1669-1679 [Abstract] [Full Text]  
• Chatterjee, A., Snead, C., Yetik-Anacak, G., Antonova, G., Zeng, J., Catravas, J. D. (2008). Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L755-L763 [Abstract] [Full Text]  
• Acevedo, L. M., Barillas, S., Weis, S. M., Gothert, J. R., Cheresh, D. A. (2008). Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 111: 2674-2680 [Abstract] [Full Text]  
• Ma, C., Rong, Y., Radiloff, D. R., Datto, M. B., Centeno, B., Bao, S., Cheng, A. W. M., Lin, F., Jiang, S., Yeatman, T. J., Wang, X.-F. (2008). Extracellular matrix protein {beta}ig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 22: 308-321 [Abstract] [Full Text]  
• Turowski, P., Martinelli, R., Crawford, R., Wateridge, D., Papageorgiou, A.-P., Lampugnani, M. G., Gamp, A. C., Vestweber, D., Adamson, P., Dejana, E., Greenwood, J. (2008). Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration. J. Cell Sci. 121: 29-37 [Abstract] [Full Text]  
• van Nieuw Amerongen, G.P., Beckers, C.M.L., Achekar, I.D., Zeeman, S., Musters, R.J.P., van Hinsbergh, V.W.M. (2007). Involvement of Rho Kinase in Endothelial Barrier Maintenance. Arterioscler. Thromb. Vasc. Bio. 27: 2332-2339 [Abstract] [Full Text]  
• Duval, M., Le B uf, F., Huot, J., Gratton, J.-P. (2007). Src-mediated Phosphorylation of Hsp90 in Response to Vascular Endothelial Growth Factor (VEGF) Is Required for VEGF Receptor-2 Signaling to Endothelial NO Synthase. Mol. Biol. Cell 18: 4659-4668 [Abstract] [Full Text]  
• Stoletov, K., Montel, V., Lester, R. D., Gonias, S. L., Klemke, R. (2007). High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc. Natl. Acad. Sci. USA 104: 17406-17411 [Abstract] [Full Text]  
• Allingham, M. J., van Buul, J. D., Burridge, K. (2007). ICAM-1-Mediated, Src- and Pyk2-Dependent Vascular Endothelial Cadherin Tyrosine Phosphorylation Is Required for Leukocyte Transendothelial Migration. J. Immunol. 179: 4053-4064 [Abstract] [Full Text]  
• Brakenhielm, E. (2007). Substrate Matters: Reciprocally Stimulatory Integrin and VEGF Signaling in Endothelial Cells. Circ. Res. 101: 536-538 [Full Text]  
• Mahabeleshwar, G. H., Feng, W., Reddy, K., Plow, E. F., Byzova, T. V. (2007). Mechanisms of Integrin Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis. Circ. Res. 101: 570-580 [Abstract] [Full Text]  
• Wang, Y., Ding, S.-J., Wang, W., Yang, F., Jacobs, J. M., Camp, D. II, Smith, R. D., Klemke, R. L. (2007). Methods for Pseudopodia Purification and Proteomic Analysis. Sci Signal 2007: pl4-pl4 [Abstract] [Full Text]  
• Johansen, M. L., Brown, E. J. (2007). Dual Regulation of SIRP{alpha} Phosphorylation by Integrins and CD47. J. Biol. Chem. 282: 24219-24230 [Abstract] [Full Text]  
• Isayeva, T., Chanda, D., Kallman, L., Eltoum, I.-E. A., Ponnazhagan, S. (2007). Effects of Sustained Antiangiogenic Therapy in Multistage Prostate Cancer in TRAMP Model. Cancer Res. 67: 5789-5797 [Abstract] [Full Text]  
• Huang, F., Reeves, K., Han, X., Fairchild, C., Platero, S., Wong, T. W., Lee, F., Shaw, P., Clark, E. (2007). Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection. Cancer Res. 67: 2226-2238 [Abstract] [Full Text]  
• Weis, S. M., Lindquist, J. N., Barnes, L. A., Lutu-Fuga, K. M., Cui, J., Wood, M. R., Cheresh, D. A. (2007). Cooperation between VEGF and {beta}3 integrin during cardiac vascular development. Blood 109: 1962-1970 [Abstract] [Full Text]  
• Chen, W., Jump, D. B., Esselman, W. J., Busik, J. V. (2007). Inhibition of Cytokine Signaling in Human Retinal Endothelial Cells through Modification of Caveolae/Lipid Rafts by Docosahexaenoic Acid. IOVS 48: 18-26 [Abstract] [Full Text]  
• Kishida, Y., Yoshikawa, H., Myoui, A. (2007). Parthenolide, a Natural Inhibitor of Nuclear Factor-{kappa}B, Inhibits Lung Colonization of Murine Osteosarcoma Cells. Clin. Cancer Res. 13: 59-67 [Abstract] [Full Text]  
• Singleton, P. A., Dudek, S. M., Ma, S.-F., Garcia, J. G. N. (2006). Transactivation of Sphingosine 1-Phosphate Receptors Is Essential for Vascular Barrier Regulation: NOVEL ROLE FOR HYALURONAN AND CD44 RECEPTOR FAMILY. J. Biol. Chem. 281: 34381-34393 [Abstract] [Full Text]  
• Moy, A. B., Blackwell, K., Wu, M. H., Granger, H. J. (2006). Growth factor- and heparin-dependent regulation of constitutive and agonist-mediated human endothelial barrier function. Am. J. Physiol. Heart Circ. Physiol. 291: H2126-H2135 [Abstract] [Full Text]  
• Gampel, A., Moss, L., Jones, M. C., Brunton, V., Norman, J. C., Mellor, H. (2006). VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment. Blood 108: 2624-2631 [Abstract] [Full Text]  
• Han, L. Y., Landen, C. N., Trevino, J. G., Halder, J., Lin, Y. G., Kamat, A. A., Kim, T.-J., Merritt, W. M., Coleman, R. L., Gershenson, D. M., Shakespeare, W. C., Wang, Y., Sundaramoorth, R., Metcalf, C. A. III, Dalgarno, D. C., Sawyer, T. K., Gallick, G. E., Sood, A. K. (2006). Antiangiogenic and Antitumor Effects of Src Inhibition in Ovarian Carcinoma.. Cancer Res. 66: 8633-8639 [Abstract] [Full Text]  
• O'Reilly, A. M., Ballew, A. C., Miyazawa, B., Stocker, H., Hafen, E., Simon, M. A. (2006). Csk differentially regulates Src64 during distinct morphological events in Drosophila germ cells. Development 133: 2627-2638 [Abstract] [Full Text]  
• Su, B., Zheng, Q., Vaughan, M. M., Bu, Y., Gelman, I. H. (2006). SSeCKS Metastasis-Suppressing Activity in MatLyLu Prostate Cancer Cells Correlates with Vascular Endothelial Growth Factor Inhibition. Cancer Res. 66: 5599-5607 [Abstract] [Full Text]  
• Gelman, I. H., Gao, L. (2006). SSeCKS/Gravin/AKAP12 Metastasis Suppressor Inhibits Podosome Formation via RhoA- and Cdc42-Dependent Pathways. Mol Cancer Res 4: 151-158 [Abstract] [Full Text]  
• Trevino, J. G., Summy, J. M., Lesslie, D. P., Parikh, N. U., Hong, D. S., Lee, F. Y., Donato, N. J., Abbruzzese, J. L., Baker, C. H., Gallick, G. E. (2006). Inhibition of Src Expression and Activity Inhibits Tumor Progression and Metastasis of Human Pancreatic Adenocarcinoma Cells in an Orthotopic Nude Mouse Model. Am. J. Pathol. 168: 962-972 [Abstract] [Full Text]  
• Summy, J. M., Gallick, G. E. (2006). Treatment for Advanced Tumors: Src Reclaims Center Stage. Clin. Cancer Res. 12: 1398-1401 [Full Text]  
• Qi, J., Wang, J., Romanyuk, O., Siu, C.-H. (2006). Involvement of Src Family Kinases in N-Cadherin Phosphorylation and beta-Catenin Dissociation during Transendothelial Migration of Melanoma Cells. Mol. Biol. Cell 17: 1261-1272 [Abstract] [Full Text]  
• Mehta, D., Malik, A. B. (2006). Signaling Mechanisms Regulating Endothelial Permeability. Physiol. Rev. 86: 279-367 [Abstract] [Full Text]  
• Summy, J. M., Trevino, J. G., Lesslie, D. P., Baker, C. H., Shakespeare, W. C., Wang, Y., Sundaramoorthi, R., Metcalf, C. A. III, Keats, J. A., Sawyer, T. K., Gallick, G. E. (2005). AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Molecular Cancer Therapeutics 4: 1900-1911 [Abstract] [Full Text]  
• Potter, M. D., Barbero, S., Cheresh, D. A. (2005). Tyrosine Phosphorylation of VE-cadherin Prevents Binding of p120- and {beta}-Catenin and Maintains the Cellular Mesenchymal State. J. Biol. Chem. 280: 31906-31912 [Abstract] [Full Text]  
• Golas, J. M., Lucas, J., Etienne, C., Golas, J., Discafani, C., Sridharan, L., Boghaert, E., Arndt, K., Ye, F., Boschelli, D. H., Li, F., Titsch, C., Huselton, C., Chaudhary, I., Boschelli, F. (2005). SKI-606, a Src/Abl Inhibitor with In vivo Activity in Colon Tumor Xenograft Models. Cancer Res. 65: 5358-5364 [Abstract] [Full Text]  
• Lambeng, N., Wallez, Y., Rampon, C., Cand, F., Christe, G., Gulino-Debrac, D., Vilgrain, I., Huber, P. (2005). Vascular Endothelial-Cadherin Tyrosine Phosphorylation in Angiogenic and Quiescent Adult Tissues. Circ. Res. 96: 384-391 [Abstract] [Full Text]  
• Weis, S., Cui, J., Barnes, L., Cheresh, D. (2004). Endothelial Barrier Disruption by VEGF-mediated Src Activity Potentiates Tumor Cell Extravasation and Metastasis. JEM 200: i10-10 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents